Chronic application of topiramate and carbamazepine differentially affects the EEG and penicillin-induced epileptiform activity in rats

Neurological Research

Volumn 34, Issue 3, 2012, Pages 246-251

  Aydin Abidin, Selcen ^a   Yildirim, Mehmet ^a   Abidin, Ismail ^a   Cansu, Ali ^a  

^a KARADENIZ TECHNICAL UNIVERSITY   (Turkey)

Author keywords

Carbamezapine; EEG; Penicillin induced epilepsy; Rat; Topiramate

Indexed keywords

CARBAMAZEPINE; PENICILLIN G; TOPIRAMATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHRONIC DRUG ADMINISTRATION; CONTROLLED STUDY; ELECTROCORTICOGRAPHY; ELECTROENCEPHALOGRAM; EPILEPSY; FEMALE; FOCAL EPILEPSY; NONHUMAN; RAT;

ANIMALS; ANTICONVULSANTS; BRAIN; CARBAMAZEPINE; DISEASE MODELS, ANIMAL; ELECTROENCEPHALOGRAPHY; EPILEPSIES, PARTIAL; FEMALE; FRUCTOSE; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84859321723     PISSN: 01616412     EISSN: 17431328     Source Type: Journal    
DOI: 10.1179/1743132812Y.0000000004     Document Type: Article

References (42)

1. Loscher W, Honack D. Profile of UCB L059, a novel anticonvulsant drug, in models of partial and generalized epilepsy in mice and rats. Eur J Pharmacol. 1993;232:147-58.
2. Stables JP, Bertram EH, White HS, Coulter DA, Dichter MA, Jacobs MP, et al. Models for epilepsy and epileptogenesis: report from the NIH workshop, Bethesda, Maryland. Epilepsia. 2002;43:1410-20.
3. White HS. Preclinical development of antiepileptic drugs: past, present, and future directions. Epilepsia. 2003;44(Suppl 7):2-8.
4. Yildirim M, Ayyildiz M, Agar E. Endothelial nitric oxide synthase activity involves in the protective effect of ascorbic acid against penicillin-induced epileptiform activity. Seizure. 2010;19:102-8.
5. Cakil D, Yildirim M, Ayyildiz M, Agar E. The effect of coadministration of the NMDA blocker with agonist and antagonist of CB1-receptor on penicillin-induced epileptiform activity in rats. Epilepsy Res. 2011;93:128-37.
6. Jefferys JG. Basic mechanisms of focal epilepsies. Exp Physiol. 1990;75:127-62.
7. Jefferys JG. Advances in understanding basic mechanisms of epilepsy and seizures. Seizure. 2010;19:638-46.
8. Weiss DS, Hablitz JJ. Interaction of penicillin and pentobarbital with inhibitory synaptic mechanisms in neocortex. Cell Mol Neurobiol. 1984;4:301-17.
9. Jefferys JG. Models and mechanisms of experimental epilepsies. Epilepsia. 2003;44:44-50.
10. Avanzini G, Franceschetti S. Cellular biology of epileptogenesis. Lancet Neurol. 2003;2:33-42.
11. Brodie MJ. Antiepileptic drug therapy the story so far. Seizure. 2010;19:650-5.
12. Dodson WE. Carbamazepine efficacy and utilization in children. Epilepsia. 1987;28(Suppl 3):S17-24.
13. Elphick M. The clinical uses and pharmacology of carbamazepine in psychiatry. Int Clin Psychopharmacol. 1988;3:185-203.
14. Willow M, Gonoi T, Catterall WA. Voltage clamp analysis of the inhibitory actions of diphenylhydantoin and carbamazepine on voltagesensitive sodium channels in neuroblastoma cells. Mol Pharmacol. 1985;27:549-58.
15. Worley PF, Baraban JM. Site of anticonvulsant action on sodium channels: autoradiographic and electrophysiological studies in rat brain. Proc Natl Acad Sci USA. 1987;84:3051-5.
16. Hough CJ, Irwin RP, Gao XM, Rogawski MA, Chuang DM. Carbamazepine inhibition of N-methyl-D-aspartate-evoked calcium influx in rat cerebellar granule cells. J Pharmacol Exp Ther. 1996;276:143-9.
17. Waldmeier PC, Baumann PA, Wicki P, Feldtrauer JJ, Stierlin C, Schmutz M. Similar potency of carbamazepine, oxcarbazepine, and lamotrigine in inhibiting the release of glutamate and other neurotransmitters. Neurology. 1995;45:1907-13.
18. Dailey JW, Reith ME, Yan QS, Li MY, Jobe PC. Anticonvulsant doses of carbamazepine increase hippocampal extracellular serotonin in genetically epilepsy-prone rats: dose response relationships. Neurosci Lett. 1997;227:13-6.
19. 2z. Eur J Pharmacol. 1997;328:153-62.
20. Marangos PJ, Post RM, Patel J, Zander K, Parma A, Weiss S. Specific and potent interactions of carbamazepine with brain adenosine receptors. Eur J Pharmacol. 1983;93:175-82.
21. Liporace JD, Sperling MR, Dichter MA. Absence seizures and carbamazepine in adults. Epilepsia. 1994;35:1026-8.
22. Parker AP, Agathonikou A, Robinson RO, Panayiotopoulos CP. Inappropriate use of carbamazepine and vigabatrin in typical absence seizures. Dev Med Child Neurol. 1998;40:517-9.
23. Gibbs JW III, Sombati S, DeLorenzo RJ, Coulter DA. Cellular actions of topiramate: blockade of kainate-evoked inward currents in cultured hippocampal neurons. Epilepsia. 2000;41(Suppl 1): S10-6.
24. Bialer M, Johanessen SI, Kupferberg HJ, Levy RH, Louiseau P, Perucca E. Progress report on new antiepileptic drugs: a summary of the Sixth Eilat Conference (EILAT VI). Epilepsy Res. 2002;51:31-71.
25. Prince DA. Topical convulsant drugs and metabolic antagonists. In: Purpura DP, Penry JK, Tower DB, Woodbury DM, Walter RD, editors. Experimental models of epilepsy. New York: Raven Press; 1972. p. 51-83.
26. Yildirim M, Marangoz C. Anticonvulsant effects of focal and intracerebroventricular adenosine on penicillin-induced epileptiform activity in rats. Brain Res. 2007;1127:193-200.
27. Aslan A, Yildirim M, Ayyildiz M, Güven A, Agar E. The role of nitric oxide in the inhibitory effect of ghrelin against penicillin-induced epileptiform activity in rat. Neuropeptides. 2009;43:295-302.
28. Clemens B, Ménes A, Piros P, Bessenyei M, Altmann A, Jerney J, et al. Quantitative EEG effects of carbamazepine, oxcarbazepine, valproate, lamotrigine, and possible clinical relevance of the findings. Epilepsy Res. 2006;70:190-9.
29. Besser R, Hornung K, Theisonh M, Rothacher G, Kramer G. EEG changes in patients during the introduction of carbamazepine. Electroenceph Clin Neurophysiol. 1992;83:19-23.
30. Meador KJ, Loring DW, Abney OL, Allen ME, Moore EE, Zamrini EY, et al. Effects of carbamazepine and phenytoin on EEG and memory in healthy adults. Epilepsia. 1993;34:153-7.
31. Konishi T, Naganuma Y, Honguo K, Murakami M, Yamatani M, Okada T. Effects of antiepileptic drugs on EEG background activity in children with epilepsy. Clin Electroenceph. 1995;26:113-9.
32. Salinsky MC, Binder LM, Oken BS, Storzbach D, Aron CR, Dodrill CB. Effects of gabapentine and carbamazepine on the EEG and cognition in healthy volunteers. Epilepsia. 2002;43:482-90.
33. Arzy S, Allali G, Brunet D, Michel CM, Kaplan PW, Seeck M. Antiepileptic drugs modify power of high EEG frequencies and their neural generators. Eur J Neurol. 2010;17:1308-12.
34. Salinsky M, Storzbach D, Oken B, Spencer D. Topiramate effects on the EEG and alertness in healthy volunteers: a different profile of antiepileptic drug neurotoxicity. Epilepsy Behav. 2007;10:463-9.
35. Mecarelli O, Piacenti A, Pulitano P, Vicenzini E, Rizzo C, Rinalduzzi S, et al. Clinical and electroencephalographic effects of topiramate in patients with epilepsy and healthy volunteers. Clin Neuropharmacol. 2001;24:284-9.
36. Saletu B, Anderer P, Kinsperger K, Grünberger J. Topographic brain mapping of EEG in neuropsychopharmacology. Part II. Clinical applications (Pharmaco EEG imaging). Meth Find Exp Clin Pharmacol. 1987;9:385-408.
37. Pellock JM. Carbamazepine side effects in children and adults. Epilepsia. 1987;28(Suppl 3):S64-70.
38. Yamazaki S, Mochizuki Y, Terai T, Sugimoto M, Uchida I, Matsuoka N, et al. Intracerebroventricular injection of the antibiotic cefoselis produces convulsion in mice via inhibition of GABA receptors. Pharmacol Biochem Behav. 2002;74:53-9.
39. Sugimoto M, Fukami S, Kayakiri H, Yamazaki S, Matsuoka N, Uchida I, et al. The b-lactam antibiotics, penicillin-G and cefoselis have different mechanisms and sites of action at GABAA receptors. Br J Pharmacol. 2002;135:427-32.
40. Courtney KR, Etter EF. Modulated anticonvulsant block of sodium channels in nerve and muscle. Eur J Pharmacol. 1983;88:1-9.
41. White HS, Brown SD, Woodhead JH, Skeen GA, Wolf HH. Topiramate enhances GABA-mediated chloride flux and GABA-evoked chloride currents in murine brain neurons and increases seizure threshold. Epilepsy Res. 1997;28: 167-79.
42. Stephen LJ, Brodie MJ. 2009. Selection of antiepileptic drugs in adults. Neurol Clin. 2009;27:967-92.